NJ State Employees Deferred Compensation Plan’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,500
Closed -$362K 30
2025
Q3
$362K Hold
10,500
0.04% 331
2025
Q2
$166K Hold
10,500
0.02% 409
2025
Q1
$134K Hold
10,500
0.02% 416
2024
Q4
$197K Hold
10,500
0.02% 421
2024
Q3
$203K Hold
10,500
0.02% 433
2024
Q2
$273K Hold
10,500
0.03% 381
2024
Q1
$300K Hold
10,500
0.04% 374
2023
Q4
$321K Hold
10,500
0.04% 367
2023
Q3
$282K Hold
10,500
0.04% 364
2023
Q2
$374K Hold
10,500
0.05% 330
2023
Q1
$267K Hold
10,500
0.04% 393
2022
Q4
$426K Hold
10,500
0.07% 298
2022
Q3
$347K Buy
+10,500
New +$424K 0.06% 328

Other funds holding ARWR

NJ State Employees Deferred Compensation Plan's ARWR Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Arrowhead Research (ARWR) in Q4 2025, closing a stake of 10,500 shares — an estimated $362K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ARWR in Q3 2022 and held it in 13 quarters. The position peaked at $426K in Q4 2022. 401 funds tracked by Wall St. Rank hold ARWR as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Arrowhead Research position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 10,500 Arrowhead Research shares in Q4 2025, an estimated $362K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Arrowhead Research in Q3 2022 and held it in 13 quarters.
  • NJ State Employees Deferred Compensation Plan's Arrowhead Research position peaked at $426K in Q4 2022.
  • 401 funds tracked by Wall St. Rank held Arrowhead Research as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.